Page last updated: 2024-11-02

pentoxifylline and Severe Dengue

pentoxifylline has been researched along with Severe Dengue in 1 studies

Severe Dengue: A virulent form of dengue characterized by THROMBOCYTOPENIA and an increase in vascular permeability (grades I and II) and distinguished by a positive pain test (e.g., TOURNIQUET PAIN TEST). When accompanied by SHOCK (grades III and IV), it is called dengue shock syndrome.

Research Excerpts

ExcerptRelevanceReference
"The current treatment for dengue hemorrhagic fever largely consists of supportive care."6.77Use of pentoxifylline in treatment of children with dengue hemorrhagic fever. ( Hatch, S; Rodriguez, J; Salgado, D; Vega, MR; Zabaleta, TE, 2012)
"The current treatment for dengue hemorrhagic fever largely consists of supportive care."2.77Use of pentoxifylline in treatment of children with dengue hemorrhagic fever. ( Hatch, S; Rodriguez, J; Salgado, D; Vega, MR; Zabaleta, TE, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salgado, D1
Zabaleta, TE1
Hatch, S1
Vega, MR1
Rodriguez, J1

Trials

1 trial available for pentoxifylline and Severe Dengue

ArticleYear
Use of pentoxifylline in treatment of children with dengue hemorrhagic fever.
    The Pediatric infectious disease journal, 2012, Volume: 31, Issue:7

    Topics: Adolescent; Child; Child, Preschool; Double-Blind Method; Female; Humans; Immunologic Factors; Infan

2012